Services

• Health Economic/Financial Modeling: Healthcare cost and utilization models, cost effectiveness/cost benefit analyses, market and policy simulations

• Policy Analysis: Evaluation of health policy on cost, quality and access for government organizations, corporations, foundations/donors, payers, multilateral institutions and other stakeholders

• Finance and Delivery Innovation: Development and evaluation of financing mechanisms or novel delivery approaches to expand access to healthcare products and services for targeted segments.

• Investment Analysis: ROI/NPV models for optimal R&D allocation or capital investment decisions; valuation models for healthcare M&A/private equity

• Market Assessment: Quantitative and qualitative research for healthcare products and services across payers/customer types at the local, country, regional or global level.

• Health Policy Briefs and Reports: Periodic publications on select health policy topics or client-commissioned reports

• Issue Roundtables: Exploration of important health finance and delivery issues in collaboration with partner institutions.

Current Key Topic Areas

• Financial instruments and financing approaches for curative medicines (e.g. gene therapy, curative treatments etc.)

• Access to medicines in low and middle income countries or challenging market segments in developed countries

• Differential pricing mechanisms

• Health systems financing (esp. private sector and human resources for health)

• R&D portfolio/capital investment decisions